{"nctId":"NCT00716859","briefTitle":"A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma.","startDateStruct":{"date":"2008-07"},"conditions":["Glaucoma"],"count":139,"armGroups":[{"label":"Timolol","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Timolol"]},{"label":"latanoprost","type":"EXPERIMENTAL","interventionNames":["Drug: latanoprost"]}],"interventions":[{"name":"Timolol","otherNames":[]},{"name":"latanoprost","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male or female of 18 years of age or under\n* Diagnosis of glaucoma\n* IOP of 22 mmHg or above in at least 1 eye\n\nExclusion Criteria:\n\n* Require surgery for acute angle closure\n* Have had prior cyclodestructive procedures\n* Have a history of ocular trauma or surgery in either eye within 3 months of the baseline visit","healthyVolunteers":false,"sex":"ALL","minimumAge":"36 Weeks","maximumAge":"18 Years","stdAges":["CHILD","ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Reduction From Baseline in Mean IOP at Week 12, Last Observation Carried Forward (LOCF)","description":"Calculated as Baseline IOP minus Week 12 IOP, LOCF. IOP measured using 1 of 3 methods: Goldmann applanation tonometry (preferred method, if feasible), Perkins tonometry, or TonoPen. IOP was measured twice and if the measurements were less than or equal to (≤) 2 millimeters of mercury (mmHg) of each other, the mean of the 2 readings was recorded as the IOP at that time point. Otherwise, a third IOP measurement was taken and the median IOP recorded.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.72","spread":"0.81"},{"groupId":"OG001","value":"7.18","spread":"0.81"}]}]}]},{"type":"SECONDARY","title":"Reduction From Baseline in Mean IOP at Week 1","description":"Calculated as Baseline IOP minus Week 1 IOP (observed). IOP measured using 1 of 3 methods: Goldmann applanation tonometry (preferred method, if feasible), Perkins tonometry, or TonoPen. IOP was measured twice and if the measurements were ≤ 2 mmHg of each other, the mean of the 2 readings was recorded as the IOP at that time point. Otherwise, a third IOP measurement was taken and the median IOP recorded.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.02","spread":"0.83"},{"groupId":"OG001","value":"6.70","spread":"0.84"}]}]}]},{"type":"SECONDARY","title":"Reduction From Baseline in Mean IOP at Week 4","description":"Calculated as Baseline IOP minus Week 4 IOP (observed). IOP measured using 1 of 3 methods: Goldmann applanation tonometry (preferred method, if feasible), Perkins tonometry, or TonoPen. IOP was measured twice and if the measurements were ≤ 2 mmHg of each other, the mean of the 2 readings was recorded as the IOP at that time point. Otherwise, a third IOP measurement was taken and the median IOP recorded.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.37","spread":"0.94"},{"groupId":"OG001","value":"6.99","spread":"0.92"}]}]}]},{"type":"SECONDARY","title":"Reduction From Baseline in Mean IOP at Week 12 (Observed)","description":"Calculated as Baseline IOP minus Week 12 IOP (observed). IOP measured using 1 of 3 methods: Goldmann applanation tonometry (preferred method, if feasible), Perkins tonometry, or TonoPen. IOP was measured twice and if the measurements were ≤ 2 mmHg of each other, the mean of the 2 readings was recorded as the IOP at that time point. Otherwise, a third IOP measurement was taken and the median IOP recorded.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.96","spread":"0.68"},{"groupId":"OG001","value":"7.75","spread":"0.66"}]}]}]},{"type":"SECONDARY","title":"Mean IOP at Baseline","description":"IOP measured using 1 of 3 methods: Goldmann applanation tonometry (preferred method, if feasible), Perkins tonometry, or TonoPen. IOP was measured twice and if the measurements were ≤ 2 mmHg of each other, the mean of the 2 readings was recorded as the IOP at that time point. Otherwise, a third IOP measurement was taken and the median IOP recorded.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"27.8","spread":"6.18"},{"groupId":"OG001","value":"27.3","spread":"5.46"}]}]}]},{"type":"SECONDARY","title":"Mean IOP at Week 1","description":"IOP measured using 1 of 3 methods: Goldmann applanation tonometry (preferred method, if feasible), Perkins tonometry, or TonoPen. IOP was measured twice and if the measurements were ≤ 2 mmHg of each other, the mean of the 2 readings was recorded as the IOP at that time point. Otherwise, a third IOP measurement was taken and the median IOP recorded.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"21.7","spread":"7.99"},{"groupId":"OG001","value":"20.6","spread":"6.38"}]}]}]},{"type":"SECONDARY","title":"Mean IOP at Week 4","description":"IOP measured using 1 of 3 methods: Goldmann applanation tonometry (preferred method, if feasible), Perkins tonometry, or TonoPen. IOP was measured twice and if the measurements were ≤ 2 mmHg of each other, the mean of the 2 readings was recorded as the IOP at that time point. Otherwise, a third IOP measurement was taken and the median IOP recorded.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"21.5","spread":"7.49"},{"groupId":"OG001","value":"20.1","spread":"6.82"}]}]}]},{"type":"SECONDARY","title":"Mean IOP at Week 12","description":"IOP measured using 1 of 3 methods: Goldmann applanation tonometry (preferred method, if feasible), Perkins tonometry, or TonoPen. IOP was measured twice and if the measurements were ≤ 2 mmHg of each other, the mean of the 2 readings was recorded as the IOP at that time point. Otherwise, a third IOP measurement was taken and the median IOP recorded.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19.8","spread":"3.50"},{"groupId":"OG001","value":"19.2","spread":"5.87"}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants With Greater Than or Equal to (≥) 15% IOP Reduction From Baseline at Both Weeks 4 and 12","description":"Participants with ≥15% IOP reduction from baseline at both Week 4 and Week 12. Calculated as (post baseline IOP minus baseline IOP) divided by IOP, multiplied by 100%. IOP measured using 1 of 3 methods: Goldmann applanation tonometry (preferred method, if feasible), Perkins tonometry, or TonoPen. IOP was measured twice and if the measurements were ≤ 2 mmHg of each other, the mean of the 2 readings was recorded as the IOP at that time point. Otherwise, a third IOP measurement was taken and the median IOP recorded.","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"52","spread":null},{"groupId":"OG001","value":"60","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants Discontinuing Therapy Due to a Drug-related Adverse Experience","description":"An investigator's causality assessment was the determination of whether there existed a reasonable possibility that the investigational product caused or contributed to an adverse event (AE). If the investigator did not know whether or not investigational product caused the event, then the event was handled as \"related to investigational product\" for reporting purposes.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.4","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":7,"n":69},"commonTop":["Nasopharyngitis","Headache","Conjunctival hyperaemia, study eye","Conjunctival hyperaemia, both eyes","Pyrexia"]}}}